Neogen Licenses Monsanto Technologies

Apr 12, 2001, 01:00 ET from Neogen Corporation

    LANSING, Mich., April 12 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG)
 announced today that it has signed a non-exclusive licensing agreement with
 Monsanto Company to access proprietary Monsanto technology to develop tests
 for the rapid detection of genetically enhanced grains.
     The tests, which will also be marketed by Neogen, will allow grain
 distributors and processors to quickly and easily identify grain developed
 through Monsanto's agricultural biotechnology.
     "Neogen has a proven history of developing products and programs to ensure
 purity standards for agricultural applications," said James Herbert, Neogen's
 president.  "Through this licensing agreement, we believe Neogen is uniquely
 positioned to help seed producers and grain processors ensure standards of
 purity effectively and inexpensively."
     Monsanto's development of new methods for plant breeding, and discovery of
 unique proteins that may be introduced into plants, is leading to crops with
 higher value for producers and consumers.
     One of the first tests Neogen will produce under the agreement will be a
 rapid and easy-to-use diagnostic test to detect the presence of the Roundup
 Ready(R) herbicide resistance trait developed by Monsanto.  This herbicide
 resistance has been incorporated into soybean seed used throughout the world.
 Soybean varieties with this trait are expected to be a large percentage of
 this year's total production in the leading soybean producing countries of the
 United States and Argentina.
     The licensing agreement also includes the development of tests to detect
 plant proteins developed for corn, cotton and canola.
     Neogen Corporation develops and markets products and services dedicated to
 food and animal safety.  The Company's Food Safety Division markets diagnostic
 test kits to detect foodborne bacteria, natural toxins, genetic modifications,
 food allergens, drug residues, plant diseases and sanitation concerns.
 Neogen's Animal Safety Division markets a complete line of diagnostics,
 veterinary instruments, veterinary pharmaceuticals, nutritional supplements
 and wound care products.
     Certain portions of this news release that do not relate to historical
 financial information constitute forward-looking statements.  These forward-
 looking statements are subject to certain risks and uncertainties.  Actual
 future results and trends may differ materially from historical results or
 those expected depending on a variety of factors listed in Management's
 Discussion and Analysis of Financial Condition and Results of Operations in
 the Company's most recently filed Form 10-K.
 
 

SOURCE Neogen Corporation
    LANSING, Mich., April 12 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG)
 announced today that it has signed a non-exclusive licensing agreement with
 Monsanto Company to access proprietary Monsanto technology to develop tests
 for the rapid detection of genetically enhanced grains.
     The tests, which will also be marketed by Neogen, will allow grain
 distributors and processors to quickly and easily identify grain developed
 through Monsanto's agricultural biotechnology.
     "Neogen has a proven history of developing products and programs to ensure
 purity standards for agricultural applications," said James Herbert, Neogen's
 president.  "Through this licensing agreement, we believe Neogen is uniquely
 positioned to help seed producers and grain processors ensure standards of
 purity effectively and inexpensively."
     Monsanto's development of new methods for plant breeding, and discovery of
 unique proteins that may be introduced into plants, is leading to crops with
 higher value for producers and consumers.
     One of the first tests Neogen will produce under the agreement will be a
 rapid and easy-to-use diagnostic test to detect the presence of the Roundup
 Ready(R) herbicide resistance trait developed by Monsanto.  This herbicide
 resistance has been incorporated into soybean seed used throughout the world.
 Soybean varieties with this trait are expected to be a large percentage of
 this year's total production in the leading soybean producing countries of the
 United States and Argentina.
     The licensing agreement also includes the development of tests to detect
 plant proteins developed for corn, cotton and canola.
     Neogen Corporation develops and markets products and services dedicated to
 food and animal safety.  The Company's Food Safety Division markets diagnostic
 test kits to detect foodborne bacteria, natural toxins, genetic modifications,
 food allergens, drug residues, plant diseases and sanitation concerns.
 Neogen's Animal Safety Division markets a complete line of diagnostics,
 veterinary instruments, veterinary pharmaceuticals, nutritional supplements
 and wound care products.
     Certain portions of this news release that do not relate to historical
 financial information constitute forward-looking statements.  These forward-
 looking statements are subject to certain risks and uncertainties.  Actual
 future results and trends may differ materially from historical results or
 those expected depending on a variety of factors listed in Management's
 Discussion and Analysis of Financial Condition and Results of Operations in
 the Company's most recently filed Form 10-K.
 
 SOURCE  Neogen Corporation